| 101 | 28270046 | Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine. | Scand J Gastroenterol | 2017 May |
5 |
| 102 | 28339085 | Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma. | Oncol Rep | 2017 May |
1 |
| 103 | 28765909 | Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells. | Oncol Rep | 2017 Oct |
5 |
| 104 | 28915583 | N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by <sup>89</sup>Zr-Trastuzumab and <sup>18</sup>F-FDG PET imaging. | Oncotarget | 2017 Aug 22 |
7 |
| 105 | 29061782 | Development and <i>In Vitro</i> Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma. | Anticancer Res | 2017 Nov |
6 |
| 106 | 29254645 | Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates. | Bioorg Med Chem Lett | 2018 Feb 1 |
4 |
| 107 | 29777904 | Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway. | Biochim Biophys Acta Mol Basis Dis | 2018 Aug |
3 |
| 108 | 30963711 | Fluorometholone modulates gene expression of ocular surface mucins. | Acta Ophthalmol | 2019 Dec |
2 |
| 109 | 31258832 | Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. | Genes Cancer | 2019 May |
1 |
| 110 | 31357127 | Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma. | Colloids Surf B Biointerfaces | 2019 Oct 1 |
1 |
| 111 | 31915505 | The Antioxidant Alpha-Lipoic Acid Inhibits Proliferation and Invasion of Human Gastric Cancer Cells via Suppression of STAT3-Mediated MUC4 Gene Expression. | Oxid Med Cell Longev | 2019 |
7 |
| 112 | 32481830 | Synthesis, characterization, and in vitro evaluation of two synergistic anticancer drug-containing hepatoma-targeting micelles formed from amphiphilic random copolymer. | Biomater Sci | 2013 Jul 4 |
1 |
| 113 | 33082357 | Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer. | Sci Rep | 2020 Oct 20 |
1 |
| 114 | 33356219 | Indole-3-propionic Acid Improved the Intestinal Barrier by Enhancing Epithelial Barrier and Mucus Barrier. | J Agric Food Chem | 2021 Feb 10 |
1 |
| 115 | 33368602 | MUC4 is expressed in alveolar rhabdomyosarcoma. | Histopathology | 2021 May |
2 |
| 116 | 33485947 | MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans. | Cancer Lett | 2021 Apr 10 |
8 |
| 117 | 33714943 | Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients. | Aging (Albany NY) | 2021 Mar 14 |
1 |
| 118 | 33941064 | Epigenetic Modification of MicroRNA-219-1 and Its Association with Glioblastoma Multiforme. | Biochemistry (Mosc) | 2021 Apr |
2 |
| 119 | 34783868 | MicroRNA-204 attenuates oxidative stress damage of renal tubular epithelial cells in calcium oxalate kidney-stone formation via MUC4-mediated ERK signaling pathway. | Urolithiasis | 2022 Feb |
3 |
| 120 | 34944818 | Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. | Cancers (Basel) | 2021 Dec 9 |
1 |